Recently I have been writing about how the federal government should not go further in bargaining or forcing down the prices of pharmaceutical drugs. Supply is elastic and the benefits from new pharma drugs are enormous. But it is not as simple as being “for higher prices.” There is also a price trajectory over time. […] The post Prices vs. price paths appeared first on Marginal REVOLUTION.
Authors
- Published in
- United States of America
- Rights
- © Tyler Cowen
